VTRSNasdaqPharmaceutical PreparationsFiscal year ends December 31
Viatris Inc
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026
$18.26−0.39 (-2.12%)
Close on Oct 19, 2026
- Market cap
- $21.24B
- P/E (TTM)
- –
- Dividend yield
- 2.63%
Viatris statistics
Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Pharmaceutical Preparations companies for comparison
Valuation
| Measure | Viatris | Industry median |
|---|---|---|
| Market Cap | $20.97B | $166.30M |
| Enterprise Value | $33.44B | $88.19M |
| PS Ratio | 1.42 | 3.65 |
| P/FCF Ratio | 10.73 | 17.44 |
| P/OCF Ratio | 9.00 | 12.98 |
Enterprise value
| Measure | Viatris | Industry median |
|---|---|---|
| EV / Sales | 2.27 | 2.51 |
| EV / EBITDA | 12.31 | 14.65 |
| EV / FCF | 17.10 | 20.86 |
Income (trailing twelve months)
| Measure | Viatris | Industry median |
|---|---|---|
| Revenue | $14.74B | $58.34M |
| Gross Profit | $5.13B | $105.94M |
| Operating Income | -$87.30M | -$21.40M |
| Pretax Income | -$662.20M | -$14.34M |
| EBITDA | $2.72B | -$16.91M |
Margins
| Measure | Viatris | Industry median |
|---|---|---|
| Gross Margin | 34.8% | 52.9% |
| Operating Margin | -0.59% | -44.0% |
| Pretax Margin | -4.49% | -13.3% |
| EBITDA Margin | 18.4% | -30.2% |
| FCF Margin | 13.3% | -9.27% |
Returns
| Measure | Viatris | Industry median |
|---|---|---|
| Return on Capital Employed (ROCE) | -0.30% | -38.1% |
Growth
| Measure | Viatris | Industry median |
|---|---|---|
| Revenue Growth (YoY) | 4.40% | 5.96% |
| FCF Growth (YoY) | 11.6% | 2.34% |
| Revenue Growth (3Y CAGR) | -4.20% | 2.25% |
| Revenue Growth (5Y CAGR) | 3.66% | 6.48% |
Balance sheet
| Measure | Viatris | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $886.50M | $61.43M |
| Total Debt | $13.35B | $118.52M |
| Net Cash (Debt) | -$12.46B | $15.35M |
| Net Cash Per Share | -$10.85 | $0.66 |
| Working Capital | $3.71B | $76.81M |
Financial position
| Measure | Viatris | Industry median |
|---|---|---|
| Current Ratio | 1.58 | 3.34 |
| Quick Ratio | 0.63 | 2.44 |
| Debt / EBITDA | 4.91 | 3.44 |
| Debt / FCF | 6.83 | 4.89 |
| Net Debt / EBITDA | 4.59 | 2.36 |
| Interest Coverage | -0.18 | -6.26 |
Cash flow (trailing twelve months)
| Measure | Viatris | Industry median |
|---|---|---|
| Operating Cash Flow | $2.33B | -$12.35M |
| Capital Expenditures | -$376.00M | -$1.08M |
| Free Cash Flow | $1.95B | -$20.22M |
| FCF Per Share | $1.70 | -$0.42 |
Efficiency
| Measure | Viatris | Industry median |
|---|---|---|
| Asset Turnover | 0.40 | 0.39 |
| Inventory Turnover | 2.34 | 2.70 |
| Revenue Per Employee | $491.24K | $404.87K |
| Employee Count | 30,000 | 74 |
Dividends and yields
| Measure | Viatris | Industry median |
|---|---|---|
| FCF Yield | 9.32% | -8.72% |
| Dividend Yield | 2.63% | 1.82% |
| Buyback Yield | 1.43% | -0.59% |
| Shareholder Yield | 4.06% | 0.00% |
| Dividend Per Share | $0.48 | $0.83 |
| Dividend Growth (YoY) | 0.00% | 2.37% |
| Years of Dividend Growth | 0 | 0 |
Shares
| Measure | Viatris | Industry median |
|---|---|---|
| Shares Outstanding | 1,148,590,000 | 58,127,000 |
| Float | 1,144,490,000 | 49,136,700 |
| Shares Held by Insiders | 0.36% | 11.6% |
| Shares Held by Institutions | 91.5% | 59.4% |
Taxes
| Measure | Viatris | Industry median |
|---|---|---|
| Income Tax | -$251.50M | $79.87K |
Scores
| Measure | Viatris | Industry median |
|---|---|---|
| Altman Z-Score | 1.13 | -0.22 |
| Beneish M-Score | -3.27 | -2.62 |
Calculated by StockData from Viatris's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.